Skip to content

The role of Vexus(Venous Excess Ultrasonography) in the management of patients in ICU

Clinical applications of the Venous excess ultrasonography (VeXus): A Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063672
Enrollment
50
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I503- Diastolic (congestive) heart failure

Interventions

Intervention1: NIL: NIL

Sponsors

SHRI BALAJI INSTITUTE OF MEDICAL SCIENCE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age =18 years 2.Presence of clinical signs of fluid overload. 3.Need loop diuretic therapy for decongestion.

Exclusion criteria

Exclusion criteria: 1.Prior Diuretic therapy 2.Pregnancy 3.Unstable Hemodynamics 4.Acute Coronary Disease 5.CPR with in 24 hrs 6.Chronic Liver Disease with Portal Hypertension and Tricuspid Disease interfering Portal Vein Assessment. 7.Permanent Atrial Fibrillation

Design outcomes

Primary

MeasureTime frame
Primary Outcome of my study will aim to use find venous congestion in patients with clinical and radiological signs of fluid overload.Timepoint: Assessment will be done on daily basis till normalisation of Venous congestion and then every third day till Icu discharge or death

Secondary

MeasureTime frame
1. Congestion grading(Using Vexus score) and different organ involvement. 2. Diuretic response in venous congestion as improvement in VeXus Score. 3. Weaning day from mechanical respiratory support. 4. ICU length . 5. Hemodynamics after vexus guided fluid desuscitation Timepoint: one year

Countries

India

Contacts

Public ContactDr Pankaj Kumar

SHRI BALAJI INSTITUTE OF MEDICAL SCIENCE

prafullaagnihotri@gmail.com9300206471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026